Ignite Creation Date:
2024-05-06 @ 4:45 PM
Last Modification Date:
2024-10-26 @ 2:15 PM
Study NCT ID:
NCT05082259
Status:
RECRUITING
Last Update Posted:
2023-08-22
First Post:
2021-10-06
Brief Title:
ASTEROID A Trial of ASTX660 in Combination With Pembrolizumab
Sponsor:
Institute of Cancer Research United Kingdom
Organization:
Institute of Cancer Research United Kingdom
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Triple Negative Breast Cancer |
| Advanced Cancer |
| Cervical Cancer |
Keywords: